Advances in the Development of Antiviral Compounds for Rotavirus Infections
Group A rotaviruses (RVAs) are the major cause of severe acute gastroenteritis (AGE) in children under 5 years of age, annually resulting in nearly 130,000 deaths worldwide. Social conditions in developing countries that contribute to decreased oral rehydration and vaccine efficacy and the lack of...
Guardado en:
Autores principales: | María Julieta Tohmé, Laura Ruth Delgui |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4f9acf65eb1487e8b511935630f3f91 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Stem Cell-Derived Human Intestinal Organoids as an Infection Model for Rotaviruses
por: Stacy R. Finkbeiner, et al.
Publicado: (2012) -
Rotavirus Infection and Cytopathogenesis in Human Biliary Organoids Potentially Recapitulate Biliary Atresia Development
por: Sunrui Chen, et al.
Publicado: (2020) -
Rotavirus Disrupts Calcium Homeostasis by NSP4 Viroporin Activity
por: Joseph M. Hyser, et al.
Publicado: (2010) -
Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity
por: Abhishek Asthana, et al.
Publicado: (2021) -
A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases
por: Zhizhen Li, et al.
Publicado: (2021)